S100A4 and cardiac hypertrophy: Though it may seem counterintuitive that an ECM-degrading fibroblast is implicated in fibrotic injury, S100A4 is similarly overexpressed in lung tissue of idiopathic pulmonary fibrosis patients as well as in cardiac hypertrophy and kidney fibrosis (53–55).